According to Biolife Solutions 's latest financial reports the company's total liabilities are $75.05 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $75.05 M | -12.77% |
2022-12-31 | $86.04 M | 12.86% |
2021-12-31 | $76.23 M | 157.71% |
2020-12-31 | $29.58 M | -40.07% |
2019-12-31 | $49.36 M | 60.08% |
2018-12-31 | $30.83 M | 1403.41% |
2017-12-31 | $2.05 M | -56.92% |
2016-12-31 | $4.76 M | 89.64% |
2015-12-31 | $2.51 M | 17.49% |
2014-12-31 | $2.13 M | -87.15% |
2013-12-31 | $16.62 M | 6.19% |
2012-12-31 | $15.65 M | 21.91% |
2011-12-31 | $12.84 M | 18.28% |
2010-12-31 | $10.85 M | 18.52% |
2009-12-31 | $9.16 M | 44.45% |
2008-12-31 | $6.34 M | 98.44% |
2007-12-31 | $3.19 M | 740.25% |
2006-12-31 | $0.38 M | -6.92% |
2005-12-31 | $0.4 M | 85.48% |
2004-12-31 | $0.22 M | -86.3% |
2003-12-31 | $1.6 M | 85.21% |
2002-12-31 | $0.86 M | -40.78% |
2001-12-31 | $1.46 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Celanese CE | $19.04 B | 25,276.08% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | $0.23 B | 215.27% | ๐บ๐ธ USA |
Amyris AMRS | $1.32 B | 1,669.13% | ๐บ๐ธ USA |